Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2004-8-25
pubmed:abstractText
The aim of this study was to determine whether there is an association between serum resistance, O serotypes, and the production of extended-spectrum beta-lactamases (ESBLs) in Klebsiella pneumoniae. Ninety ESBL-producing and 178 non-ESBL-producing K. pneumoniae isolates gathered in five European countries were O serotyped and tested for sensitivity to the serum's bactericidal effect. The frequency of serum-resistant isolates was higher among ESBL-producing strains (30%; 27/90 isolates) than among non-ESBL-producing strains (17.9%; 32/178 isolates) (P = 0.037; odds ratio [OR] = 1.96; 95% confidence interval [95% CI] = 1.08 to 3.53). Although O1 was the most common O serotype in both Klebsiella groups, its frequency among ESBL-producing strains was significantly higher (59%; 53/90 isolates) than among non-ESBL producers (36%; 64/178 isolates) (P = 0.0006; OR = 2.5; 95% CI = 1.52 to 4.29). Furthermore, the prevalence of the O1 serotype was higher among serum-resistant strains of both ESBL-producing (74%; 20/27isolates) and non-ESBL producers (75%; 24/32 isolates) than among serum-sensitive ESBL producers (52.4%; 33/63 isolates) and non-ESBL producers (27.4%; 40/146 isolates). Serum resistance among ESBL-producing strains (36%; 17/47 isolates) versus non-ESBL-producing strains (16%; 27/166 isolates) was also significantly higher after the exclusion of clonal strains (P = 0.0056; OR = 2.9; 95% CI = 1.41 to 6.01). Sixteen ESBL types were detected, among which the frequency of serum resistance was significantly lower among the SHV-producing strains (9/48 isolates) than among the TEM producers (16/35 isolates) (P = 0.016; OR = 3.65; CI = 1.3 to 9.7). Curing ESBL-coding plasmids did not influence the serum resistance of the bacteria; all six plasmid-cured derivatives maintained serum resistance. The present findings suggest that ESBL-producing strains have a greater pathogenic potential than non-ESBL-producing strains, but the linkage between O serotypes, serum resistance, and ESBL production remains unclear at this stage.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-10449457, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-10582907, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-1107450, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-11796363, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-12199849, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-12621091, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-1345909, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-1587619, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-3263690, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-3312009, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-3531020, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-3804440, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-6195306, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-6343827, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-7526122, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-7902383, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-825532, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-8432605, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-8675336, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-8712771, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-8818891, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-8889716, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-8890232, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-9158741, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-9163469, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-9302204, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-9646106, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-9675457, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-9767057, http://linkedlifedata.com/resource/pubmed/commentcorrection/15328114-9854064
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3477-82
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.
pubmed:affiliation
Department of Medical Microbiology and Virology, University of Kiel, Brunswiker Str. 4, 24105 Kiel, Germany. sahly@medmicrobio.uni-kiel.de
pubmed:publicationType
Journal Article